Scotia Capital’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $118K | Sell |
73,989
-50
| -0.1% | -$80 | ﹤0.01% | 821 |
|
|
2025
Q1 | $90.3K | Buy |
74,039
+50
| +0.1% | +$61 | ﹤0.01% | 814 |
|
|
2024
Q4 | $140K | Buy |
73,989
+41,023
| +124% | +$77.5K | ﹤0.01% | 809 |
|
|
2024
Q3 | $176K | Hold |
32,966
| – | – | ﹤0.01% | 783 |
|
|
2024
Q2 | $243K | Buy |
32,966
+9,271
| +39% | +$68.4K | ﹤0.01% | 722 |
|
|
2024
Q1 | $283K | Buy |
23,695
+9,491
| +67% | +$113K | ﹤0.01% | 700 |
|
|
2023
Q4 | $112K | Sell |
14,204
-2,718
| -16% | -$21.4K | ﹤0.01% | 762 |
|
|
2023
Q3 | $74.8K | Buy |
16,922
+13,673
| +421% | +$60.4K | ﹤0.01% | 743 |
|
|
2023
Q2 | $113K | Buy |
+3,249
| New | +$113K | ﹤0.01% | 746 |
|